|
|
Purpose : From a societal perspective, we evaluated the cost-effectiveness of a novel sustained-release injection of recombinant human growth hormone (GH) administered on a weekly basis compared with that of the present daily GH injection for the treatment of children with GH deficiency.
Methods : Health-related utility for GH therapy was measured based on the visual analogue scale. During July... |
